Published in Cancer Lett on December 18, 2015
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility. Front Endocrinol (Lausanne) (2016) 0.75
IL-8 Is Involved in Estrogen-Related Receptor α-Regulated Proliferation and Migration of Colorectal Cancer Cells. Dig Dis Sci (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
The evolution of cancer of the colon and rectum. Cancer (1975) 9.05
Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science (1997) 6.60
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
Allelotype of colorectal carcinomas. Science (1989) 5.54
Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A (1985) 4.58
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology (1999) 3.67
Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol (2005) 3.44
Update on the serrated pathway to colorectal carcinoma. Hum Pathol (2010) 2.78
Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology (2006) 2.49
Screening colonoscopy for colorectal cancer in asymptomatic people: a meta-analysis. Dig Dis Sci (2008) 2.03
Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol (1997) 1.87
Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res (2001) 1.85
Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology (2010) 1.83
Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell (2008) 1.82
Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med (2006) 1.80
Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem (1994) 1.76
A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene (2007) 1.69
Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer (2003) 1.65
Selective loss of estrogen receptor beta in malignant human colon. Cancer Res (2000) 1.63
Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene (2000) 1.62
Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res (2007) 1.61
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res (1997) 1.56
Estrogen stimulates the expression of mismatch repair gene hMLH1 in colonic epithelial cells. Cancer Prev Res (Phila) (2010) 1.51
Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci U S A (2006) 1.49
Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res (2009) 1.43
Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer (2001) 1.42
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev (2010) 1.41
Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess (2010) 1.40
Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res (2009) 1.40
Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol (2009) 1.39
Gender differences in colorectal polyps and tumors. Am J Gastroenterol (2001) 1.35
Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res (2009) 1.32
Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study. Cancer Epidemiol Biomarkers Prev (2009) 1.29
The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell (2014) 1.28
Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis (2005) 1.24
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res (2008) 1.24
Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol (2008) 1.19
Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res (2007) 1.17
Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep (2005) 1.15
The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer (2011) 1.14
Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res (2010) 1.10
Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats. Cancer Prev Res (Phila) (2008) 1.09
Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res (2001) 1.05
Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol (2002) 1.05
ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol (2005) 1.03
Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol (2011) 1.03
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice. Carcinogenesis (2009) 1.02
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol (2014) 1.01
Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer. Carcinogenesis (2004) 1.01
Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2000) 1.01
Quantitative molecular assay for fingerprinting microbial communities of wastewater and estrogen-degrading consortia. Appl Environ Microbiol (2005) 1.01
Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 0.99
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer (2005) 0.97
Expression of oestrogen receptor β and prognosis of colorectal cancer. Br J Cancer (2012) 0.97
Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med (2008) 0.96
Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res (2009) 0.96
Expression and prognostic value of transcription factor PROX1 in colorectal cancer. Br J Cancer (2011) 0.96
Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice. Int J Cancer (2008) 0.95
Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer. Gut (2013) 0.94
Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer. Tumour Biol (2010) 0.94
Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway. Pharm Res (2009) 0.92
Estrogen receptor-β protects against colitis-associated neoplasia in mice. Int J Cancer (2012) 0.92
Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner. Chin J Physiol (2006) 0.89
Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Carcinogenesis (2009) 0.89
Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr (2004) 0.89
Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells. Carcinogenesis (2013) 0.89
Chemopreventive effect of ERβ-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice. Mol Carcinog (2010) 0.88
ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis. Scand J Gastroenterol (2010) 0.88
Expression of estrogen receptor beta in human colorectal cancer. World J Gastroenterol (2004) 0.88
Oestrogen and colorectal cancer: mechanisms and controversies. Int J Colorectal Dis (2013) 0.87
Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol (2008) 0.87
Diet complexity and estrogen receptor β status affect the composition of the murine intestinal microbiota. Appl Environ Microbiol (2013) 0.87
Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-β. Cancer Res (2013) 0.87
ER-beta expression in large bowel adenomas: implications in colon carcinogenesis. Dig Liver Dis (2008) 0.86
Chemoprevention of colorectal cancer-experimental and clinical aspects-. J Med Invest (2009) 0.86
Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res (2012) 0.86
Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells. J Cancer Res Clin Oncol (2012) 0.85
Signal transduction cross-talk during colorectal tumorigenesis. Adv Anat Pathol (2006) 0.84
A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation. Endocr Relat Cancer (2013) 0.83
Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling. Carcinogenesis (2013) 0.83
Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study. Am J Gastroenterol (2010) 0.83
Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells. Endocr Relat Cancer (2014) 0.83
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study. World J Gastroenterol (2013) 0.82
Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer. Tumour Biol (2012) 0.82
Estrogen receptor-β gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake. Int J Cancer (2012) 0.82
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis. World J Gastroenterol (2013) 0.81
Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. Phytomedicine (2009) 0.81
P53 mediates estradiol induced activation of apoptosis and DNA repair in non-malignant colonocytes. J Steroid Biochem Mol Biol (2011) 0.79
Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: a preliminary report. Scand J Gastroenterol (2012) 0.77
Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats. Cancer Prev Res (Phila) (2013) 0.77
Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy. J Cancer Res Clin Oncol (2014) 0.77
The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma. Scand J Gastroenterol (2015) 0.77
Genetic variation in insulin pathway genes and distal colorectal adenoma risk. Int J Colorectal Dis (2012) 0.76
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila) (2014) 0.76
Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner. Pflugers Arch (2014) 0.75